Michael Kays

1.3k total citations
43 papers, 990 citations indexed

About

Michael Kays is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Michael Kays has authored 43 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 23 papers in Epidemiology and 15 papers in Molecular Medicine. Recurrent topics in Michael Kays's work include Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (22 papers) and Antibiotic Resistance in Bacteria (15 papers). Michael Kays is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (22 papers) and Antibiotic Resistance in Bacteria (15 papers). Michael Kays collaborates with scholars based in United States, South Korea and Canada. Michael Kays's co-authors include Kevin M. Sowinski, Hairui Liang, David W. Smith, Matthew F. Wack, S. Christian Cheatham, Gerald A. Denys, Eun Kyoung Chung, Daniel P. Healy, Katherine M. Shea and Bruce A. Mueller and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Orthopaedics and Related Research and American Journal of Kidney Diseases.

In The Last Decade

Michael Kays

42 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kays United States 19 722 431 237 148 127 43 990
Isabelle Delattre Belgium 16 646 0.9× 394 0.9× 219 0.9× 207 1.4× 50 0.4× 21 1.0k
Scott Briscoe Australia 10 764 1.1× 411 1.0× 270 1.1× 253 1.7× 87 0.7× 10 1.0k
Marta Ulldemolins Spain 13 888 1.2× 564 1.3× 326 1.4× 281 1.9× 87 0.7× 24 1.1k
Arantxa Isla Spain 24 951 1.3× 451 1.0× 393 1.7× 200 1.4× 64 0.5× 59 1.6k
Mieke Carlier Belgium 19 944 1.3× 515 1.2× 379 1.6× 281 1.9× 110 0.9× 24 1.1k
Peggy Gandia France 16 404 0.6× 293 0.7× 152 0.6× 100 0.7× 43 0.3× 75 1.0k
Martin G. Kees Germany 17 443 0.6× 196 0.5× 140 0.6× 90 0.6× 65 0.5× 37 724
Otto Frey Germany 18 1.1k 1.6× 660 1.5× 411 1.7× 334 2.3× 88 0.7× 47 1.5k
Bernhard X. Mayer Austria 19 597 0.8× 192 0.4× 144 0.6× 107 0.7× 137 1.1× 26 1.2k
C H Nightingale United States 17 657 0.9× 427 1.0× 325 1.4× 115 0.8× 42 0.3× 37 1.0k

Countries citing papers authored by Michael Kays

Since Specialization
Citations

This map shows the geographic impact of Michael Kays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kays more than expected).

Fields of papers citing papers by Michael Kays

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kays. The network helps show where Michael Kays may publish in the future.

Co-authorship network of co-authors of Michael Kays

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kays. A scholar is included among the top collaborators of Michael Kays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kays. Michael Kays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Eun Kyoung, et al.. (2016). Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients. Annals of Pharmacotherapy. 51(3). 209–218. 7 indexed citations
2.
Cheatham, S. Christian, et al.. (2016). Total and Unbound Cefazolin Pharmacokinetics and Pharmacodynamics in Non-Obese and Obese Patients. Open Forum Infectious Diseases. 3(suppl_1).
3.
Cheatham, S. Christian, et al.. (2013). Steady‐state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit. The Journal of Clinical Pharmacology. 54(3). 324–330. 29 indexed citations
4.
5.
Cheatham, S. Christian, et al.. (2012). Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients. International Journal of Antimicrobial Agents. 41(1). 52–56. 37 indexed citations
6.
Jacobi, Judith, et al.. (2011). Steady‐State Pharmacokinetics of Intravenous Levetiracetam in Neurocritical Care Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(10). 934–941. 48 indexed citations
7.
Cheatham, S. Christian, Katherine M. Shea, Daniel P. Healy, et al.. (2010). Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients. International Journal of Antimicrobial Agents. 37(1). 46–50. 22 indexed citations
8.
Cheatham, S. Christian, Michael Kays, David W. Smith, Matthew F. Wack, & Kevin M. Sowinski. (2008). Steady‐State Pharmacokinetics and Pharmacodynamics of Meropenem in Hospitalized Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(6). 691–698. 19 indexed citations
9.
10.
Kays, Michael, George G. Zhanel, Judith Jacobi, et al.. (2007). Selection of a gyrA Mutation and Treatment Failure with Gatifloxacin in a Patient with Streptococcus pneumoniae with a Preexisting parC Mutation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(2). 221–226. 6 indexed citations
11.
Zhang, Xin, Brian R. Overholser, Michael Kays, & Kevin M. Sowinski. (2006). Gatifloxacin Pharmacokinetics in Healthy Men and Women. The Journal of Clinical Pharmacology. 46(10). 1154–1162. 3 indexed citations
12.
Kays, Michael, et al.. (2005). Effect of Ensure on the Oral Bioavailability of Gatifloxacin in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(11). 1530–1535. 4 indexed citations
13.
Overholser, Brian R., et al.. (2005). Pharmacokinetics of Intravenously Administered Levofloxacin in Men and Women. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(10). 1310–1318. 10 indexed citations
14.
Overholser, Brian R., Michael Kays, Alan Forrest, & Kevin M. Sowinski. (2004). Sex‐Related Differences in the Pharmacokinetics of Oral Ciprofloxacin. The Journal of Clinical Pharmacology. 44(9). 1012–1022. 23 indexed citations
15.
Sowinski, Kevin M., Aroonrut Lucksiri, Michael Kays, et al.. (2003). Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer. American Journal of Kidney Diseases. 42(2). 342–349. 12 indexed citations
16.
Kays, Michael, Matthew F. Wack, David W. Smith, & Gerald A. Denys. (2002). Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. Diagnostic Microbiology and Infectious Disease. 43(2). 163–165. 29 indexed citations
17.
Kays, Michael, et al.. (2002). Broth Microdilution and E-Test for Determining Fluoroquinolone Activity against Streptococcus Pneumoniae. Annals of Pharmacotherapy. 36(3). 416–422. 8 indexed citations
18.
Kays, Michael, et al.. (1999). In Vitro Activity and Pharmacodynamics of Oral β‐Lactam Antibiotics Against Streptococcus pneumoniae from Southeast Missouri. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(11). 1308–1314. 9 indexed citations
19.
Kays, Michael. (1999). Comparison of Five β‐Lactam Antibiotics Against Common Nosocomial Pathogens Using the Time Above MIC at Different Creatinine Clearances. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(12). 1392–1399. 9 indexed citations
20.
Friedrich, Lawrence V., et al.. (1990). The Effect of Tourniquet Inflation on Cefazolin Tissue Penetration During Total Knee Arthroplasty. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(6). 373–377. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Delattre Breakdown of academic impact, for papers by Scott Briscoe Breakdown of academic impact, for papers by Marta Ulldemolins Breakdown of academic impact, for papers by Arantxa Isla Breakdown of academic impact, for papers by Mieke Carlier Breakdown of academic impact, for papers by Peggy Gandia Breakdown of academic impact, for papers by Martin G. Kees Breakdown of academic impact, for papers by Otto Frey Breakdown of academic impact, for papers by Bernhard X. Mayer Breakdown of academic impact, for papers by C H Nightingale
Rankless by CCL
2026